Alnylam Pharmaceuticals
May 2, 2008
Public relations, press release distribution, investor relations, SEC filing
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that it will report financial results for the first - 05/02/2008 - 04:00 PM MINNEAPOLIS-- --Urologix , Inc. via Business Wire
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

